Voya Investment Management LLC cut its stake in UnitedHealth Group Inc (NYSE:UNH) by 3.5% during the 2nd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 2,438,768 shares of the healthcare conglomerate’s stock after selling 89,510 shares during the quarter. UnitedHealth Group comprises about 1.3% of Voya Investment Management LLC’s investment portfolio, making the stock its 5th biggest position. Voya Investment Management LLC owned 0.25% of UnitedHealth Group worth $598,327,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Other large investors also recently added to or reduced their stakes in the company. FMR LLC increased its position in shares of UnitedHealth Group by 5.1% during the second quarter. FMR LLC now owns 61,622,355 shares of the healthcare conglomerate’s stock worth $15,118,428,000 after acquiring an additional 2,981,233 shares during the last quarter. Wells Fargo & Company MN increased its position in shares of UnitedHealth Group by 0.5% during the second quarter. Wells Fargo & Company MN now owns 7,692,899 shares of the healthcare conglomerate’s stock worth $1,887,377,000 after acquiring an additional 39,480 shares during the last quarter. Jennison Associates LLC increased its position in shares of UnitedHealth Group by 12.0% during the second quarter. Jennison Associates LLC now owns 6,616,652 shares of the healthcare conglomerate’s stock worth $1,623,329,000 after acquiring an additional 710,745 shares during the last quarter. Summit Trail Advisors LLC increased its position in shares of UnitedHealth Group by 19,286.4% during the first quarter. Summit Trail Advisors LLC now owns 6,228,065 shares of the healthcare conglomerate’s stock worth $6,228,000 after acquiring an additional 6,195,939 shares during the last quarter. Finally, Schwab Charles Investment Management Inc. increased its position in shares of UnitedHealth Group by 2.8% during the second quarter. Schwab Charles Investment Management Inc. now owns 4,019,885 shares of the healthcare conglomerate’s stock worth $986,239,000 after acquiring an additional 108,052 shares during the last quarter. 85.31% of the stock is currently owned by institutional investors.

Shares of UnitedHealth Group stock opened at $266.67 on Monday. The company has a debt-to-equity ratio of 0.63, a current ratio of 0.75 and a quick ratio of 0.75. The stock has a market capitalization of $256.66 billion, a P/E ratio of 26.48, a PEG ratio of 1.59 and a beta of 0.71. UnitedHealth Group Inc has a fifty-two week low of $186.00 and a fifty-two week high of $271.16.

UnitedHealth Group (NYSE:UNH) last announced its quarterly earnings data on Tuesday, July 17th. The healthcare conglomerate reported $3.14 earnings per share for the quarter, beating the Thomson Reuters’ consensus estimate of $3.04 by $0.10. The firm had revenue of $56.09 billion during the quarter, compared to analyst estimates of $56.10 billion. UnitedHealth Group had a return on equity of 22.79% and a net margin of 5.55%. UnitedHealth Group’s quarterly revenue was up 12.1% on a year-over-year basis. During the same period in the previous year, the company earned $2.46 earnings per share. equities research analysts anticipate that UnitedHealth Group Inc will post 12.72 earnings per share for the current fiscal year.

UnitedHealth Group declared that its Board of Directors has approved a share buyback plan on Wednesday, June 6th that authorizes the company to repurchase 100,000,000 shares. This repurchase authorization authorizes the healthcare conglomerate to purchase shares of its stock through open market purchases. Stock repurchase plans are typically an indication that the company’s leadership believes its stock is undervalued.

The company also recently disclosed a quarterly dividend, which was paid on Tuesday, September 18th. Investors of record on Friday, September 7th were issued a $0.90 dividend. This represents a $3.60 annualized dividend and a yield of 1.35%. The ex-dividend date of this dividend was Thursday, September 6th. UnitedHealth Group’s dividend payout ratio is currently 35.75%.

In other UnitedHealth Group news, CEO Steven H. Nelson sold 26,033 shares of UnitedHealth Group stock in a transaction that occurred on Friday, September 7th. The stock was sold at an average price of $270.65, for a total value of $7,045,831.45. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, Director Kenneth Irwin Shine sold 177 shares of UnitedHealth Group stock in a transaction that occurred on Wednesday, July 18th. The shares were sold at an average price of $255.72, for a total value of $45,262.44. Following the completion of the transaction, the director now owns 29,053 shares of the company’s stock, valued at $7,429,433.16. The disclosure for this sale can be found here. Over the last three months, insiders sold 94,745 shares of company stock valued at $24,995,290. 0.87% of the stock is owned by corporate insiders.

UNH has been the topic of a number of analyst reports. Morgan Stanley lifted their target price on UnitedHealth Group from $277.00 to $278.00 and gave the stock a “$255.42” rating in a research report on Wednesday, July 18th. Citigroup lifted their target price on UnitedHealth Group from $275.00 to $288.00 and gave the stock a “$255.42” rating in a research report on Wednesday, July 18th. Royal Bank of Canada lifted their target price on UnitedHealth Group from $282.00 to $284.00 and gave the stock a “$255.42” rating in a research report on Wednesday, July 18th. Goldman Sachs Group reaffirmed a “buy” rating and set a $277.00 target price on shares of UnitedHealth Group in a research report on Tuesday, July 17th. Finally, Zacks Investment Research raised UnitedHealth Group from a “hold” rating to a “buy” rating and set a $287.00 target price on the stock in a research report on Sunday, July 15th. Three equities research analysts have rated the stock with a hold rating and twenty-one have given a buy rating to the stock. The company currently has a consensus rating of “Buy” and an average price target of $274.05.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. It operates through four segments: UnitedHealthcare, OptumHealth, OptumInsight, and OptumRx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older, addressing their needs for preventive and acute health care services, as well as services dealing with chronic disease and other specialized issues for older individuals; and Medicaid plans, Children's Health Insurance Program, and health care programs; and health and dental benefits.

See Also: Average Daily Trade Volume – What You Need to Know

Institutional Ownership by Quarter for UnitedHealth Group (NYSE:UNH)

Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.